Decorin Potentiates Interferon-γ Activity in a Model of Allergic Inflammation
Overview
Authors
Affiliations
The proteoglycan decorin modulates leukocyte recruitment during delayed-type hypersensitivity responses. Decorin-deficient (Dcn(-/-)) mice show reduced edema formation during the first 24 h with a concurrent attenuated recruitment of CD8(+) leukocytes in the inflamed Dcn(-/-) ears. The aim of this study was to elucidate the molecular pathways affected by the loss of decorin. In vivo, reduced numbers of CD8(+) cells in Dcn(-/-) ears correlated with a reduced interferon-γ (Ifn-γ) and CXCL-10 expression. In vitro, Dcn(-/-) lymphocytes displayed an increased adhesion to brain microvascular (bEnd.3) endothelial cells. Decorin treatment of bEnd.3 increased Icam1 and down-regulated Vcam1 expression after TNF-α stimulation. However, Dcn(-/-) and wild-type lymphocytes produced IFN-γ after activation with CD3ε. Upon incubation with decorin, endothelial cells and fibroblasts responded differently to IFN-γ and TNF-α; CCL2 in bEnd.3 cells was more prominently up-regulated by TNF-α compared with IFN-γ. Notably, both factors were more potent in the presence of decorin. Compared with TNF-α, IFN-γ treatment induced significantly more CXCL-10, and both factors increased synthesis of CXCL-10 in the presence of decorin. The response to IFN-γ was similar in Dcn(-/-) and wild-type fibroblasts, an additional source of CXCL-10. However, addition of decorin yielded significantly more CXCL-10. Notably, decorin increased the stability of IFN-γ in vitro and potentiated IFN-γ-induced activation of STAT-1. Furthermore, only dermatan sulfate influenced IFN-γ signaling by significantly increasing CXCL-10 expression in contrast to decorin protein core alone. Our data demonstrate that decorin modulates delayed-type hypersensitivity responses by augmenting the induction of downstream effector cytokines of IFN-γ and TNF-α, thereby influencing the recruitment of CD8(+) lymphocytes into the inflamed tissue.
Buraschi S, Pascal G, Liberatore F, Iozzo R Proteoglycan Res. 2025; 3(1).
PMID: 40066261 PMC: 11893098. DOI: 10.1002/pgr2.70014.
Chen X, Dai Y, Li Y, Xin J, Zou J, Wang R Front Aging Neurosci. 2024; 16:1430290.
PMID: 39258145 PMC: 11384588. DOI: 10.3389/fnagi.2024.1430290.
Ito S, Koshino A, Wang C, Otani T, Komura M, Ueki A J Pathol Clin Res. 2024; 10(4):e12386.
PMID: 38890810 PMC: 11187867. DOI: 10.1002/2056-4538.12386.
Yang Y, Chen H, Jiang Q, Yang L, Zhu R, Huang N Front Genet. 2024; 15:1287111.
PMID: 38495671 PMC: 10940350. DOI: 10.3389/fgene.2024.1287111.
Miguez P, Bash E, Musskopf M, Tuin S, Rivera-Concepcion A, Chapple I Periodontol 2000. 2023; 94(1):510-531.
PMID: 37614159 PMC: 10891305. DOI: 10.1111/prd.12515.